Charles Schwab Investment Management Inc Vertex Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,663,849 shares of VRTX stock, worth $818 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,663,849
Previous 1,626,347
2.31%
Holding current value
$818 Million
Previous $756 Million
11.42%
% of portfolio
0.13%
Previous 0.15%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,757Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.9 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.4 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.5 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.89 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.13 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...